Euro-Med Laboratories Phil., Inc. (PSE:EURO)
Philippines · Delayed Price · Currency is PHP 1.060
0.00 (0.00%)
At close: Jun 3, 2026
PSE:EURO Cash Flow Statement
Financials in millions PHP. Fiscal year is January - December.
Millions PHP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 486.88 | 470.3 | 337.68 | 289.95 | 199.89 | 169.05 |
Depreciation & Amortization | 379.1 | 398.89 | 329.59 | 298.23 | 286.89 | 278.33 |
Loss (Gain) From Sale of Assets | - | - | -36.45 | - | - | - |
Loss (Gain) From Sale of Investments | -45.64 | -45.64 | -22.47 | -13.23 | 1.09 | -43.93 |
Provision & Write-off of Bad Debts | 8.1 | 8.1 | 16.86 | 3.69 | 4.25 | 13.17 |
Other Operating Activities | 91.22 | 62.97 | -17.23 | 27.23 | 19.61 | 14.88 |
Change in Accounts Receivable | -7.67 | -58.11 | -316.16 | -187.32 | -64.71 | 211.04 |
Change in Inventory | 256.72 | 159.29 | -48.89 | -156.16 | -272.43 | 132.05 |
Change in Accounts Payable | -52.34 | -56.72 | -94.29 | 167.63 | 28.74 | -353.51 |
Change in Other Net Operating Assets | -35.79 | 31.64 | 98.17 | -75.9 | -55.09 | 67.33 |
Operating Cash Flow | 1,081 | 970.72 | 246.81 | 354.13 | 148.23 | 488.4 |
Operating Cash Flow Growth | 264.88% | 293.31% | -30.30% | 138.90% | -69.65% | 10.78% |
Capital Expenditures | -243.67 | -267.93 | -196.08 | -291.87 | -88.89 | -285.57 |
Sale of Property, Plant & Equipment | - | - | 43.14 | - | - | - |
Sale (Purchase) of Intangibles | -2 | -2 | - | - | - | - |
Investment in Securities | -28.66 | -28.66 | - | - | - | 72.85 |
Investing Cash Flow | -274.34 | -298.6 | -152.94 | -291.87 | -88.89 | -212.72 |
Short-Term Debt Issued | - | 3,139 | 3,135 | 3,478 | 2,399 | 1,884 |
Long-Term Debt Issued | - | 330 | 209.79 | 309.7 | 64 | 598.8 |
Total Debt Issued | 2,888 | 3,469 | 3,345 | 3,788 | 2,463 | 2,483 |
Short-Term Debt Repaid | - | -3,181 | -3,109 | -3,097 | -2,049 | -2,243 |
Long-Term Debt Repaid | - | -323.99 | -107.37 | -349.5 | -271.96 | -475 |
Total Debt Repaid | -2,932 | -3,505 | -3,216 | -3,447 | -2,321 | -2,718 |
Net Debt Issued (Repaid) | -43.44 | -36.16 | 128.62 | 341.32 | 142.36 | -235.68 |
Common Dividends Paid | -287.85 | -287.85 | -246.73 | -143.92 | -143.92 | - |
Financing Cash Flow | -331.29 | -324.01 | -118.11 | 197.39 | -1.56 | -235.68 |
Foreign Exchange Rate Adjustments | 0.02 | 0.02 | 0.51 | 5.98 | 3.43 | 6.08 |
Net Cash Flow | 474.98 | 348.13 | -23.73 | 265.63 | 61.21 | 46.09 |
Free Cash Flow | 836.92 | 702.78 | 50.73 | 62.26 | 59.35 | 202.83 |
Free Cash Flow Growth | 993.87% | 1285.29% | -18.52% | 4.91% | -70.74% | - |
Free Cash Flow Margin | 12.23% | 10.23% | 0.88% | 1.18% | 1.41% | 5.65% |
Free Cash Flow Per Share | 0.19 | 0.17 | 0.01 | 0.01 | 0.01 | 0.05 |
Cash Interest Paid | 289.55 | 289.55 | 295.57 | 261 | 196.45 | 206.8 |
Cash Income Tax Paid | 137.37 | 137.37 | 140.38 | 95.04 | 68.89 | 86.43 |
Levered Free Cash Flow | 720.44 | 592.23 | 65.15 | 2.47 | -57.12 | 123.61 |
Unlevered Free Cash Flow | 908.37 | 780.16 | 257.52 | 171.5 | 72.13 | 256.85 |
Change in Working Capital | 160.93 | 76.1 | -361.17 | -251.74 | -363.5 | 56.91 |